Regeneron Pharmaceuticals Inc.
REGN | NASDAQ
$965.06
+$37.17 (+4.01%)
Nov 2, 2026, 3:42 PM ET · Market open
TTM Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 16.9B | 15.53B | 14.92B | 14.34B | 14.25B | 14.21B | 14.09B | 14.2B | 13.85B | 13.49B | 13.1B | 13.12B | 13.1B | 12.67B | 12.37B | 12.17B | 13.71B | 14.23B | 16.51B | 16.07B | 13.54B | 12.38B | 9.2B |
Cost of Revenue | 2.4B | 2.35B | 2.31B | 2.1B | 2.08B | 2.05B | 2B | 1.97B | 2.03B | 2.08B | 2.11B | 2.24B | 2.11B | 1.98B | 1.85B | 1.77B | 2.32B | 2.43B | 2.83B | 2.72B | 2.08B | 1.89B | 1.46B |
Gross Profit | 14.49B | 13.18B | 12.61B | 12.24B | 12.17B | 12.16B | 12.08B | 12.23B | 11.81B | 11.4B | 10.99B | 10.88B | 10.98B | 10.69B | 10.52B | 10.4B | 11.39B | 11.79B | 13.68B | 13.35B | 11.46B | 10.5B | 7.74B |
Operating Income | 4.99B | 3.97B | 3.63B | 3.58B | 3.69B | 3.84B | 3.83B | 3.99B | 4.05B | 4.08B | 4.03B | 4.28B | 4.55B | 4.56B | 4.85B | 5.13B | 6.46B | 7.08B | 9.12B | 8.95B | 7.47B | 6.68B | 3.99B |
Interest Income | 741.9M | 735.2M | 726.7M | 716.7M | 706.5M | 718.8M | 723.4M | 711.4M | 677M | 623.3M | 562.2M | 400.7M | 252M | 118.3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 5.69B | 5.17B | 5.16B | 5.23B | 5.15B | 4.87B | 4.98B | 4.78B | 4.97B | 4.59B | 4.04B | 4.2B | 4.38B | 4.78B | 4.66B | 4.86B | 6.04B | 6.34B | 9.13B | 9.33B | 8.05B | 7.23B | 4.39B |
Net Income | 4.82B | 4.33B | 4.42B | 4.5B | 4.58B | 4.46B | 4.5B | 4.41B | 4.65B | 4.32B | 3.86B | 3.95B | 3.99B | 4.3B | 4.18B | 4.34B | 5.37B | 5.69B | 7.93B | 8.08B | 7B | 6.21B | 4B |
Selling & General & Admin | 2.76B | 2.74B | 2.71B | 2.7B | 2.72B | 2.77B | 2.9B | 2.95B | 2.87B | 2.79B | 2.69B | 2.6B | 2.55B | 2.44B | 2.26B | 2.11B | 2.02B | 1.93B | 1.87B | 1.82B | 1.57B | 1.45B | 1.38B |
Research & Development | 6.72B | 6.46B | 6.26B | 5.96B | 5.76B | 5.53B | 5.32B | 5.23B | 4.86B | 4.5B | 4.26B | 4B | 3.9B | 3.74B | 3.48B | 3.25B | 3.02B | 2.79B | 2.72B | 2.62B | 2.59B | 2.63B | 2.65B |
Other Expenses | 18.7M | 8.7M | 8.7M | 8.7M | 5.5M | 23.5M | 38.1M | 53.4M | 37.4M | 28.9M | 13.7M | -2.1M | -8.2M | -53.4M | -70.2M | -89.9M | -99.1M | -11.4M | -25.3M | -45.6M | -175M | -261.6M | -280.5M |
Operating Expenses | 9.5B | 9.21B | 8.98B | 8.66B | 8.48B | 8.32B | 8.25B | 8.24B | 7.76B | 7.32B | 6.96B | 6.6B | 6.44B | 6.13B | 5.68B | 5.27B | 4.94B | 4.71B | 4.56B | 4.4B | 3.99B | 3.82B | 3.75B |
Interest Expense | 46.7M | 55.4M | 48M | 43.8M | 42.1M | 36.6M | 47.8M | 55.2M | 63M | 67M | 71.1M | 73M | 72.1M | 69.6M | 63.8M | 59.4M | 56.1M | 55M | 56.3M | 57.3M | 58M | 70.1M | 65.4M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 11.9B | 11.56B | 11.29B | 10.77B | 10.56B | 10.37B | 10.25B | 10.21B | 9.8B | 9.41B | 9.07B | 8.84B | 8.55B | 8.11B | 7.52B | 7.04B | 7.25B | 7.15B | 7.39B | 7.12B | 6.07B | 5.7B | 5.21B |
Income Tax Expense | 869.4M | 837.3M | 733.5M | 725.8M | 567.1M | 416.2M | 484.9M | 367.3M | 314.9M | 265.5M | 184.2M | 245.7M | 385.3M | 476.4M | 473M | 520.4M | 667.2M | 657.5M | 1.2B | 1.25B | 1.05B | 1.02B | 391M |
Shares Outstanding (Basic) | 101.7M | 103.4M | 104M | 102.9M | 103.62M | 105.1M | 106.7M | 107.9M | 108.1M | 108.1M | 107.8M | 106.6M | 106.3M | 107M | 107.1M | 107M | 112.8M | 114M | 113.07M | 106.2M | 106.2M | 105M | 110.5M |
Shares Outstanding (Diluted) | 105.6M | 106.8M | 107.7M | 107.5M | 107.2M | 108.6M | 111.2M | 113.8M | 116.2M | 115.4M | 115.1M | 113.8M | 113.4M | 113.9M | 114M | 114M | 112.8M | 114M | 113.1M | 113.2M | 113.9M | 110.8M | 110.53M |
EPS (Basic) | 46.95 | 41.88 | 42.53 | 43.12 | 43.44 | 41.75 | 41.76 | 40.88 | 43.23 | 40.31 | 36.11 | 37.05 | 37.36 | 39.54 | 37.96 | 38.93 | 48.73 | 52.44 | 74.48 | 76.45 | 66.37 | 58.98 | 37.65 |
EPS (Diluted) | 45.26 | 40.43 | 41.04 | 41.56 | 41.76 | 39.68 | 39.28 | 38.28 | 40.41 | 37.76 | 33.85 | 34.75 | 35.06 | 37.83 | 36.80 | 38.24 | 47.43 | 50.10 | 70.60 | 72.08 | 62.63 | 55.69 | 35.33 |
EBITDA | 6.25B | 5.75B | 5.74B | 5.82B | 5.71B | 5.42B | 5.53B | 5.32B | 5.5B | 5.11B | 4.55B | 4.69B | 4.86B | 5.24B | 5.09B | 5.26B | 6.41B | 6.7B | 9.48B | 9.67B | 8.38B | 7.56B | 4.71B |
EBIT | 5.73B | 5.22B | 5.2B | 5.27B | 5.19B | 4.91B | 5.03B | 4.84B | 5.03B | 4.65B | 4.11B | 4.27B | 4.45B | 4.85B | 4.72B | 4.92B | 6.09B | 6.4B | 9.19B | 9.38B | 8.11B | 7.3B | 4.46B |
Depreciation & Amortization | 512.9M | 528.6M | 540M | 543.7M | 525.1M | 510.1M | 495.7M | 482.9M | 469.5M | 453.2M | 435.6M | 421M | 408.1M | 395.3M | 366.6M | 341.4M | 315.8M | 296.4M | 293.1M | 286.2M | 273.4M | 259.5M | 247.2M |
Add to Watchlist
Select watchlists to add or remove REGN